A review of hepatic nanotoxicology - summation of recent findings and considerations for the next generation of study designs.


Journal

Journal of toxicology and environmental health. Part B, Critical reviews
ISSN: 1521-6950
Titre abrégé: J Toxicol Environ Health B Crit Rev
Pays: England
ID NLM: 9802627

Informations de publication

Date de publication:
18 05 2020
Historique:
pubmed: 24 4 2020
medline: 28 8 2020
entrez: 24 4 2020
Statut: ppublish

Résumé

The liver is one of the most important multi-functional organs in the human body. Amongst various crucial functions, it is the main detoxification center and predominantly implicated in the clearance of xenobiotics potentially including particulates that reach this organ. It is now well established that a significant quantity of injected, ingested or inhaled nanomaterials (NMs) translocate from primary exposure sites and accumulate in liver. This review aimed to summarize and discuss the progress made in the field of hepatic nanotoxicology, and crucially highlight knowledge gaps that still exist.Key considerations include

Identifiants

pubmed: 32321383
doi: 10.1080/10937404.2020.1751756
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

137-176

Auteurs

Ali Kermanizadeh (A)

School of Engineering and Physical Sciences, Heriot Watt University, Edinburgh, UK.
School of Medical Sciences, Bangor University, Bangor, UK.

Leagh G Powell (LG)

School of Engineering and Physical Sciences, Heriot Watt University, Edinburgh, UK.

Vicki Stone (V)

School of Engineering and Physical Sciences, Heriot Watt University, Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH